Abstract
Addiction is a chronic, relapsing disorder comprising three stages: binge, withdrawal, and preoccupation. Preclinical evidence suggests that the habenula, a small epithalamic region, is involved across these stages and may contribute to long-term neuroadaptations in reward, stress, and control systems. Human research on the habenula in addiction is growing but remains fragmented. This scoping review synthesizes human evidence on the habenula in addiction and assesses convergence with preclinical models. Following PRISMA-ScR guidelines, databases and grey literature were searched in November 2025. Studies were included if they examined habenular measures in relation to addiction in humans, and findings were synthesized by measure category: volume, structural connectivity, functional connectivity, activity, and genetic measures. Within each category, findings were interpreted by addiction stage where applicable. Nineteen studies were included. Across categories, studies reported reduced fronto–habenula white-matter integrity, elevated habenula–striatal resting-state functional connectivity, and withdrawal-related habenula–frontal connectivity. By contrast, volumetric studies did not find consistent evidence linking habenula volume to addiction status. Activity findings included increased habenula blood flow during withdrawal, as well as task-based fMRI evidence of reduced differentiation between positive and negative feedback and heightened reward responses. Genetic findings most consistently implicated nicotine-related habenula signaling. Human findings converged most clearly with preclinical models for withdrawal and nicotine mechanisms, but no domain showed direct one-to-one human–preclinical alignment. Several domains were either one-sided, based on non-equivalent measures, or absent in both literatures. Future studies using comparable designs are needed to clarify how the habenula contributes to addiction.